Cantourage Group SE Sustainability Reports

Cantourage Group SE operates as a medical cannabis company that produces and distributes dried flowers, extracts, dronabinol, and pharma-grade cannabidiol products. The company distributes its medical products to pharmacies, wholesalers, and healthcare partners throughout Europe and internationally.

Sector: Manufacturing

Country: Germany

Exchange: Deutsche Börse (Xetra)

LEI: 3912003NCTLO6YHA9V48

FIGI: BBG01BGRPGC1

3 reports from 2023 to 2025

• Cantourage Group SE 2025 Annual Financial Statements
• Cantourage Group SE 2024 Consolidated Financial Statements
• Cantourage Group SE 2023 Annual Financial Statements